Omeros Corporation - stock earnings
OMER Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -37.8 million USD | ? USD |
| 2023Q2 | -37.3 million USD | ? USD |
| 2023Q1 | -33.7 million USD | ? USD |
| 2022Q4 | 128.7 million USD | ? USD |
| 2022Q3 | 33.3 million USD | ? USD |
| 2022Q2 | 6.6 million USD | ? USD |
| 2022Q1 | -37.5 million USD | ? USD |
| 2021Q4 | 280.6 million USD | -79.9 million USD |
| 2021Q3 | -22.7 million USD | 30.0 million USD |
| 2021Q2 | -28.6 million USD | 28.8 million USD |
| 2021Q1 | -35.1 million USD | 21.1 million USD |
| 2020Q4 | -37.3 million USD | 10.6 million USD |
| 2020Q3 | -38.5 million USD | 26.1 million USD |
| 2020Q2 | -33.3 million USD | 13.5 million USD |
| 2020Q1 | -29.0 million USD | 23.5 million USD |
| 2019Q4 | -29.2 million USD | 33.4 million USD |
| 2019Q3 | -16.5 million USD | 29.9 million USD |
| 2019Q2 | -14.5 million USD | 26.8 million USD |
| 2019Q1 | -24.3 million USD | 21.8 million USD |
| 2018Q4 | -23.5 million USD | 22.0 million USD |
| 2018Q3 | -39.5 million USD | 4.6 million USD |
| 2018Q2 | -33.7 million USD | 1.7 million USD |
| 2018Q1 | -30.1 million USD | 1.6 million USD |
| 2017Q4 | -16.6 million USD | 13.8 million USD |
| 2017Q3 | -7.5 million USD | 21.7 million USD |
| 2017Q2 | -14.4 million USD | 17.2 million USD |
| 2017Q1 | -15.1 million USD | 12.3 million USD |
| 2016Q4 | -19.6 million USD | 12.9 million USD |
| 2016Q3 | -14.0 million USD | 11.3 million USD |
| 2016Q2 | -12.6 million USD | 10.0 million USD |
| 2016Q1 | -20.5 million USD | 7.4 million USD |
| 2015Q4 | -19.8 million USD | 6.7 million USD |
| 2015Q3 | -19.9 million USD | 3.3 million USD |
| 2015Q2 | -16.7 million USD | 3.2 million USD |
| 2015Q1 | -18.7 million USD | 388000 USD |
| 2014Q4 | -20.7 million USD | 180000 USD |
| 2014Q3 | -18.3 million USD | 214000 USD |
| 2014Q2 | -18.0 million USD | 45000 USD |
| 2014Q1 | -16.6 million USD | 100000 USD |
| 2013Q4 | -1.8 million USD | 169000 USD |
| 2013Q3 | -13.9 million USD | 196000 USD |
| 2013Q2 | -13.6 million USD | 140000 USD |
| 2013Q1 | -10.5 million USD | 1.1 million USD |
| 2012Q4 | -7.7 million USD | 1.6 million USD |
| 2012Q3 | -13.3 million USD | 1.4 million USD |
| 2012Q2 | -8.5 million USD | 1.5 million USD |
| 2012Q1 | -8.9 million USD | 1.5 million USD |
| 2011Q4 | -10.2 million USD | 1.1 million USD |
| 2011Q3 | -6.5 million USD | 987000 USD |
| 2011Q2 | -5.3 million USD | 1.2 million USD |
| 2011Q1 | -6.5 million USD | 1.2 million USD |
| 2010Q4 | -7.2 million USD | 976000 USD |
| 2010Q3 | -7.6 million USD | 254000 USD |
| 2010Q2 | -7.8 million USD | 497000 USD |
| 2010Q1 | -6.7 million USD | 378000 USD |
| 2009Q4 | -5.6 million USD | 434000 USD |
| 2009Q3 | -3.9 million USD | 442000 USD |
| 2009Q2 | -6.1 million USD | 371000 USD |
| 2009Q1 | -5.5 million USD | 197000 USD |
| 2008Q4 | -6.4 million USD | 181000 USD |
| 2008Q3 | -7.4 million USD | 501000 USD |
| 2008Q2 | ? USD | 488000 USD |
| 2007Q4 | ? USD | 1.9 million USD |
OMER Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 20.0 million USD | ? USD |
| 2022 | 28.8 million USD | ? USD |
| 2021 | 194.2 million USD | 90.5 million USD |
| 2020 | -138.1 million USD | 73.8 million USD |
| 2019 | -106.9 million USD | 111.8 million USD |
| 2018 | -126.8 million USD | 29.9 million USD |
| 2017 | -53.5 million USD | 64.8 million USD |
| 2016 | -66.7 million USD | 41.6 million USD |
| 2015 | -75.1 million USD | 13.5 million USD |
| 2014 | -73.7 million USD | 539000 USD |
| 2013 | -39.8 million USD | 1.6 million USD |
| 2012 | -38.4 million USD | 6.0 million USD |
| 2011 | -28.5 million USD | 4.5 million USD |
| 2010 | -29.3 million USD | 2.1 million USD |
| 2009 | -21.1 million USD | 1.4 million USD |
| 2008 | -23.8 million USD | 1.2 million USD |
| 2007 | -23.1 million USD | 1.9 million USD |
| 2006 | -22.8 million USD | 200000 USD |
OMER
Price: $3.73
52 week price:
Earnings Per Share: -2.89 USD
P/E Ratio: -1.32
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 328300
Ebitda: -4.6 millionMarket Capitalization: 198.0 million